These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 37839359)
1. Potential roles of the exosome/microRNA axis in breast cancer. Mamalo AS; Alivirdiloo V; Sadeghnejad A; Hajiabbasi M; Gargari MK; Valilo M Pathol Res Pract; 2023 Nov; 251():154845. PubMed ID: 37839359 [TBL] [Abstract][Full Text] [Related]
3. Exosomal microRNA: a novel biomarker for breast cancer. He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358 [TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities. Salehi M; Sharifi M J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells. Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal cancer drug resistance: the role of exosomal miRNAs. Salehi M; Vafadar A; Khatami SH; Taheri-Anganeh M; Vakili O; Savardashtaki A; Negahdari B; Naeli P; Behrouj H; Ghasemi H; Movahedpour A Mol Biol Rep; 2022 Mar; 49(3):2421-2432. PubMed ID: 34850336 [TBL] [Abstract][Full Text] [Related]
7. Exosomes and exosomal RNAs in breast cancer: A status update. Lakshmi S; Hughes TA; Priya S Eur J Cancer; 2021 Feb; 144():252-268. PubMed ID: 33373870 [TBL] [Abstract][Full Text] [Related]
8. Plasma exosome microRNAs are indicative of breast cancer. Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715 [TBL] [Abstract][Full Text] [Related]
9. Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review. Francavilla A; Turoczi S; Tarallo S; Vodicka P; Pardini B; Naccarati A Mutagenesis; 2020 Jul; 35(3):243-260. PubMed ID: 31784760 [TBL] [Abstract][Full Text] [Related]
10. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma. Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996 [TBL] [Abstract][Full Text] [Related]
11. Cell-to-cell communication: microRNAs as hormones. Bayraktar R; Van Roosbroeck K; Calin GA Mol Oncol; 2017 Dec; 11(12):1673-1686. PubMed ID: 29024380 [TBL] [Abstract][Full Text] [Related]
12. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021 [TBL] [Abstract][Full Text] [Related]
13. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases. Hwang S; Yang YM Arch Pharm Res; 2021 Jun; 44(6):574-587. PubMed ID: 34165701 [TBL] [Abstract][Full Text] [Related]
14. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599 [TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNAs: novel players in cervical cancer. Nahand JS; Vandchali NR; Darabi H; Doroudian M; Banafshe HR; Moghoofei M; Babaei F; Salmaninejad A; Mirzaei H Epigenomics; 2020 Sep; 12(18):1651-1660. PubMed ID: 32957811 [TBL] [Abstract][Full Text] [Related]
16. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis. Ghaemmaghami AB; Mahjoubin-Tehran M; Movahedpour A; Morshedi K; Sheida A; Taghavi SP; Mirzaei H; Hamblin MR Cell Commun Signal; 2020 Aug; 18(1):120. PubMed ID: 32746854 [TBL] [Abstract][Full Text] [Related]
17. Exosome and exosomal microRNA: trafficking, sorting, and function. Zhang J; Li S; Li L; Li M; Guo C; Yao J; Mi S Genomics Proteomics Bioinformatics; 2015 Feb; 13(1):17-24. PubMed ID: 25724326 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069 [TBL] [Abstract][Full Text] [Related]
19. Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period. Frørup C; Mirza AH; Yarani R; Nielsen LB; Mathiesen ER; Damm P; Svare J; Engelbrekt C; Størling J; Johannesen J; Mortensen HB; Pociot F; Kaur S Front Immunol; 2021; 12():744509. PubMed ID: 34691048 [TBL] [Abstract][Full Text] [Related]
20. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer. Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]